Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -3.50 (-3.08%)
Bid:
108.00
Ask:
112.00
Spread: 4.00 (3.704%)
Market Cap: £108.69m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Result of Annual General Meeting

5 Jun 2026 11:30

RNS Number : 2315H
Golden Prospect Precious Metals Ltd
05 June 2026
Β 

5 June 2026

Β 

GOLDEN PROSPECT PRECIOUS METALS LIMITED (the "Company")

Β 

Result of Annual General Meeting

Β 

The Company announces the results of voting on the resolutions at its Annual General Meeting ("AGM") held at 1 Royal Plaza, Royal Avenue, St Peter Port, Guernsey, GY1 2HL on 5 June 2026.

A poll was held on each resolution and all resolutions were passed by the required majority.

Β 

Β 

Β 

ORDINARY RESOLUTIONS

FOR

AGAINST

TOTAL VOTES

VOTES WITHHELD*

Β 

Votes

Β 

%

Β 

Votes

Β 

%

1. To receive the Company's Annual Report and Audited Financial Statements for the year-ended 31 December 2025.

18,071,525

Β 

99.99

Β 

1,152

Β 

0.01

Β 

18,072,677

Β 

59,034

Β 

2. To re-appoint BDO Limited as auditor to the Company until the conclusion of the next general meeting at which accounts are laid before the Company.

Β 

17,780,024

Β 

98.38

Β 

292,653

Β 

1.62

Β 

18,072,677

Β 

59,034

Β 

3. To authorise the Directors of the Company to determine the remuneration of the auditor.

Β 

17,839,028

Β 

98.79

Β 

218,649

Β 

1.21

Β 

18,057,677

Β 

74,034

Β 

4. To re-elect Mr Toby Birch as a non-executive Director of the Company who retires in accordance with recommendations of the AIC Corporate Governance Code.

Β 

12,458,797

Β 

95.11

Β 

640,659

Β 

4.89

Β 

13,099,456

Β 

5,032,255

Β 

5. To re-elect Ms Monica Tepes as the non-executive Chair of the Company who retires in accordance with the recommendations of the AIC Corporate Governance Code.

Β 

12,707,407

Β 

96.90

Β 

406,086

Β 

3.10

Β 

13,113,493

Β 

5,018,218

Β 

6. To re-elect Mrs Helen Green as a non-executive Director of the Company who retires in accordance with recommendations of the AIC Corporate Governance Code.

Β 

12,681,141

Β 

96.80

Β 

418,791

Β 

3.20

Β 

13,099,932

Β 

5,031,779

Β 

7.Β To elect Mr Christopher Waldron as a non-executive Director of the Company who retires in accordance with Article 21.2 of the Articles of the Company.

Β 

12,708,523

Β 

96.91

Β 

405,446

Β 

3.09

Β 

13,113,969

Β 

5,017,742

Β 

8. To authorise the Company, in accordance with Article 4.8 of the Articles of Association of the Company and The Companies (Guernsey) Law, 2008, as amended (the "Law"), to make market purchases of its own ordinary shares of Β£0.001 each ("Ordinary Shares"), such authorisation conditional upon the Ordinary Shares of the Company continuing to be admitted to listing on The International Stock Exchange ("TISE") and, with the exception of a tender offer or partial offer being made to all holders of Ordinary Shares on the same terms:

Β 

8.1 the maximum number of Ordinary Shares hereby authorised to be purchased shall be up to 14.99% of the Company's existing issued ordinary share capital;

Β 

8.2 the minimum price (exclusive of expenses) which may be paid for the Ordinary Shares to be Β£0.001 per Ordinary Share;

Β 

8.3 the maximum price (exclusive of expenses) payable by the Company for the Ordinary Shares to be 5% above the average of the closing middle market quotations (as derived from Bloomberg) of an Ordinary Share for the five (5) consecutive dealing days preceding the date on which the purchase is made;

Β 

8.4 the authority (unless previously renewed or revoked) will expire at the end of the annual general meeting of the Company to be held in 2026 or, if earlier, the date being eighteen months from the date of passing of this resolution;

Β 

8.5 the Company may make a contract to purchase its own Ordinary Shares under the authority hereby conferred prior to the expiry of such authority which will or may be executed or wholly or partly executed after the expiry of such authority, and may make a purchase of its own Ordinary Shares in pursuance of any such contract; and

Β 

8.6 the purchase price for any Ordinary Shares may be paid by the Company out of distributable profits or out of capital and share premium or otherwise to the fullest extent permitted by The Companies (Financial Assistance for Acquisition of Own Shares) Ordinance, 1998.

Β 

17,688,792

Β 

97.87

Β 

385,625

Β 

2.13

Β 

18,074,417

Β 

57,294

Β 

Β 

*A 'vote withheld' is not a vote in law and is not counted towards the proportion of votes 'for' and 'against' a resolution.

Β 

Β 

Enquiries

Β 

Manulife | CQS Investment Management

Craig Cleland

Β 

Β 

+44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Robert Peel (Corporate Finance)

Daniel Balabanoff / Pauline Tribe (Sales)

Β 

Β 

+44 (0) 20 7908 6000

+44 (0) 20 7720 0500

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

Β 

Β 

+44 (0) 203 5303 600

Tavistock

Jos Simson / Gareth Tredway / Eliza Logan

Β 

+44 (0) 20 7920 3150

Β 

About Golden Prospect Precious MetalsΒ 

Β 

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals mining sector.Β 

Β 

For the latest factsheet and other information, clickβ€―here.Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RAGAKPBBKBKDQAK
Date   Source Headline
5th Jun 20262:00 pmRNSTransaction in Own Shares
5th Jun 202612:27 pmRNSNet Asset Value(s)
5th Jun 202611:30 amRNSResult of Annual General Meeting
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 202611:54 amRNSNet Asset Value(s)
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 202612:07 pmRNSNet Asset Value(s)
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:17 pmRNSNet Asset Value(s)
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20262:03 pmRNSNet Asset Value(s)
1st Jun 20261:13 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 202611:59 amRNSNet Asset Value(s)
29th May 20267:00 amRNSTransaction in Own Shares
28th May 202612:36 pmRNSNet Asset Value(s)
28th May 20267:00 amRNSTransaction in Own Shares
27th May 202611:49 amRNSNet Asset Value(s)
27th May 20269:30 amRNSTransaction in Own Shares
26th May 20264:44 pmRNSMonthly Investor Report - April 2026
26th May 20261:38 pmRNSNet Asset Value(s)
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20264:34 pmRNSCorrection of Diluted Net Asset Value per Share
22nd May 202612:11 pmRNSNet Asset Value(s)
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 202612:09 pmRNSNet Asset Value(s)
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20261:50 pmRNSNet Asset Value(s)
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20264:54 pmRNSNet Asset Value(s)
19th May 20267:00 amRNSPortfolio Management Update
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20262:48 pmRNSNet Asset Value(s)
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20263:09 pmRNSNet Asset Value(s)
15th May 20267:00 amRNSTransaction in Own Shares
14th May 202612:29 pmRNSNet Asset Value(s)
14th May 20267:00 amRNSNotice of Annual General Meeting & Form of Proxy
14th May 20267:00 amRNSTransaction in Own Shares
13th May 202612:54 pmRNSNet Asset Value(s)
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202612:03 pmRNSNet Asset Value(s)
11th May 20261:56 pmRNSNet Asset Value(s)
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20261:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSTransaction in Own Shares
7th May 202611:55 amRNSNet Asset Value(s)
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20261:06 pmRNSNet Asset Value(s)
6th May 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.